The Characteristics of Hospitalized Pneumonia Patients among Malaysian Hajj Pilgrims
Abstract
Background : Hajj is the largest annual gatherings in the Islamic world. Hajj pilgrims encounter a great deal of heavy physical and mental stress. Chest infection, especially pneumonia is a potentially life-threatening illness which poses global health problems, particularly among elderly performing hajj. The objective of this study was to identify the sociodemographic, clinical and laboratory characteristics of patients clinically suspected of having pneumonia during Hajj season. Methods: A cross-sectional study was conducted on Malaysian hajj pilgrims who were admitted to Tabung Haji (medical center) in Makkah with clinical diagnosis of pneumonia. The relevant patient’s data were recorded from the hospital information system. Results: A total number of 157 Hajj pilgrims clinically diagnosed as pneumonia were recruited during the 2012/2013 Hajj season. Pneumonia affected male more than females (55.4% and 44.6%), with a mean age of 69.4(10.0) years. Coughing (96.2%) was recorded as the commonest symptoms followed by fever (84.7%) and breathlessness (47.1%). Most of the pilgrims were noted to have hypertension (60.5%) while 28.0% of them had diabetes, chronic obstructive pulmonary disease (25.5%) and asthma (12.7%). The laboratory finding showed mean white blood cell count was 16.9 (13.0) x10 9 L, and the neutrophils differential count was 81.1% (15.5). The most frequently prescribed antibiotic is levofloxacin (54.8%), followed by azithromycin (39.2%) and cefuroxime (23.6%).…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.